Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit claiming the drug company’s subsidiary Janssen Pharmaceuticals committed Medicaid fraud and violated state law in its promotion and labeling of the antipsychotic Risperdal to Arkansas doctors. The lawsuit was originally filed in 2008. Three years ago, a Pulaski County jury found the drug company guilty of the charges and imposed a $1.2 million fine on Johnson & Johnson. The Arkansas Supreme Court overturned the decision. Janssen Pharmaceuticals said the settlement agreement is not an admission of guilt. Risperdal, known generically as risperidone, was originally approved by the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.